A weak inverse association was seen between CRC risk and fruit and vegetable consumption; risk reduction was greatest when intake increased from low levels.
Instructions to patients with regard to diet and colorectal cancer (CRC) often include decreasing consumption of dietary fat — especially animal fat — and increasing consumption of fiber, fruits, vegetables, and low-fat dairy products. However, increased intake of whole grains has not been effective in reducing the recurrence of adenomas, and epidemiologic data on the effect of fruits and vegetables have been mixed.
Now, researchers have conducted a meta-analysis of 19 cohort studies investigating fruit and vegetable intake and CRC risk. All 19 studies were included in a comparison between highest and lowest intakes; 15 were included in a dose-response analysis. Five studies were conducted in Europe, 10 in the U.S., and 4 in Asia.
The relative risk for CRC with highest versus lowest intake was 0.92 (95% confidence interval, 0.86–0.99) for fruits and vegetables and 0.90 (95% CI, 0.83–0.98) for fruits alone. For fruits, the dose-response analysis suggested a nonlinear association, with most of the risk reduction occurring when low intake increased to about 100 g per day. High vegetable intake also offered significant protection (RR, 0.91; 95% CI, 0.86–0.96). The benefits were restricted to colon cancer, and the risk reduction was nonlinear, with the greatest reduction occurring when low intake increased to about 100 g per day.
Reviewing Author
DisclosuresConsultant/Advisory BoardOlympus Corporation America; Boston Scientific
Speaker’s BureauOlympus
Grant/Research SupportMedtronic; Boston Scientific; Colonary Solutions; Paion Medical; Medivators; Braintree Laboratories
Editorial BoardsWorld Journal of Gastroenterology; The Journal of Clinical Gastroenterology; Techniques in Gastrointestinal Endoscopy; Gastroenterology & Hepatology; Expert Review of Gastroenterology & Hepatology; Medscape Gastroenterology; World Journal of Gastrointestinal Pharmacology and Therapeutics; Annals of Gastroenterology & Hepatology; World Journal of Gastrointestinal Oncology; Comparative Effectiveness Research; Journal of Anesthesia & Clinical Research; Gastroenterology; World Journal of Gastrointestinal Pathophysiology; Gastroenterology Research and Practice; GI & Hepatology News; Gastroenterology Report; Clinical Epidemiology Reviews; JSM Gastroenterology and Hepatology; GI Journal Watch; Austin Journal of Gastroenterology; World Journal of Gastrointestinal Pharmacology & Therapeutics
Leadership Positions in Professional SocietiesAmerican Society for Gastrointestinal Endoscopy (Treasurer); US Multi-Society Task Force (AGA, ACG, ASGE) (Chair)
DisclosuresConsultant/Advisory BoardOlympus Corporation America; Boston Scientific
Speaker’s BureauOlympus
Grant/Research SupportMedtronic; Boston Scientific; Colonary Solutions; Paion Medical; Medivators; Braintree Laboratories
Editorial BoardsWorld Journal of Gastroenterology; The Journal of Clinical Gastroenterology; Techniques in Gastrointestinal Endoscopy; Gastroenterology & Hepatology; Expert Review of Gastroenterology & Hepatology; Medscape Gastroenterology; World Journal of Gastrointestinal Pharmacology and Therapeutics; Annals of Gastroenterology & Hepatology; World Journal of Gastrointestinal Oncology; Comparative Effectiveness Research; Journal of Anesthesia & Clinical Research; Gastroenterology; World Journal of Gastrointestinal Pathophysiology; Gastroenterology Research and Practice; GI & Hepatology News; Gastroenterology Report; Clinical Epidemiology Reviews; JSM Gastroenterology and Hepatology; GI Journal Watch; Austin Journal of Gastroenterology; World Journal of Gastrointestinal Pharmacology & Therapeutics
Leadership Positions in Professional SocietiesAmerican Society for Gastrointestinal Endoscopy (Treasurer); US Multi-Society Task Force (AGA, ACG, ASGE) (Chair)
Citation(s):
Aune D et al. Nonlinear reduction in risk for colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies. Gastroenterology 2011 Jul; 141:106.
Comment
Gastroenterologists are often asked about drugs, supplements, and lifestyle or dietary factors that can reduce the risk for CRC. I encounter these questions most often in the recovery area after colonoscopy. Regular use of aspirin and other nonsteroidal anti-inflammatory drugs has the clearest and strongest benefit but also carries a risk for bleeding. Calcium supplementation seems beneficial, with some increased risk for kidney stones. Folate supplementation has a modest benefit, with negligible risk, particularly in patients who have already undergone clearing colonoscopy. Lifestyle factors — including normalization of body weight, regular exercise, and cessation of smoking — can be strongly recommended. Increased intake of fruits and vegetables might have some benefit, and the current study provides a new finding that the greatest advantage is in individuals with very low current intake. Of course, eating more fruits and vegetables could bring other health benefits as well.